The Global Hospital Acquired Infection Control Market is projected to reach USD 31.2 billion by 2020 and is growing at a CAGR of 8.3% during the forecast period from 2015 to 2021. Hospital acquired infections are also called as nosocomial infections and are acquired in hospitals and other healthcare facilities.
These infections can occur up to 48 hours after hospital admission or up to 3 days after discharge or up to 30 days after an operation or in a healthcare facility, when the patient was admitted for reasons other than infection.
The global hospital acquired infection control market is categorized on the basis of Pathogen Types (Viral, Bacterial, and Fungal), Treatment (Air, Water, Physical Surfaces, Skin Disinfectants, and Sterilization), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, Hospital Acquired Pneumonia, Gastrointestinal Infections, and Tuberculosis), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
These infections are usually caused by pathogens which spread at a very fast rate in the body. Also due to the patientsâ weak immune system and poor conditions in a hospital, the infections spread at a greater speed than the normal infections.
These infections are treated by taking antibiotics, by eating a proper & healthy diet, and by encouraging natural healing process. The infection can be prevented by keeping the hospital facility premises and surroundings clean as well. The most common type of hospital acquired infections is a urinary tract infection.
The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infection, awareness regarding the use of personalized medicines, and cost-effective drugs to treat hospital acquired infections are some of the factors that are driving the growth of this market.
However, the lack of awareness regarding hospital acquired infection and increased usage of outpatient treatment are hampering the growth of this market.
The major players in this market are Pfizer, Roche, Merck, Johnson & Johnson, Abott, Bayer, Nordion, and Cepheid among others.
Key Deliverables in the Study:
Global, regional, and country-level analysis along with forecasts of the study market
Study of the effect of exogenous & endogenous factors, viz. demographic, economics, and political factors, among others, which affect the global market
Porterâs five forces framework incorporating the factors influencing each force to determine the intensity of competition
Segment and sub-segment level analysis of the market over the review and forecast period
Identification of key factors instrumental in changing the market scenario, exploiting new opportunities and gaining competitive edge
SWOT analysis for key players and a detailed study of their current strategic interests and key financial performance indicatorss
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)